CN Patent

CN115768404B — 含乌美溴铵和三苯乙酸维兰特罗的药物制剂

Assigned to Guangzhou Anovent Pharmaceutical Co Ltd · Expires 2024-11-08 · 2y expired

What this patent protects

本发明涉及液体药物制剂和通过在吸入器中雾化药物制剂来施用药物制剂的方法。不含抛射剂的药物制剂包括：(a)活性物质选自乌美溴铵和三苯乙酸维兰特罗；(b)溶剂；(c)药理学上可接受的增溶剂；(d)药理学上可接受的防腐剂；(e)药理学上可接受的稳定剂；并且任选地包括其他药学上可接受的添加剂。

USPTO Abstract

本发明涉及液体药物制剂和通过在吸入器中雾化药物制剂来施用药物制剂的方法。不含抛射剂的药物制剂包括：(a)活性物质选自乌美溴铵和三苯乙酸维兰特罗；(b)溶剂；(c)药理学上可接受的增溶剂；(d)药理学上可接受的防腐剂；(e)药理学上可接受的稳定剂；并且任选地包括其他药学上可接受的添加剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN115768404B
Jurisdiction
CN
Classification
—
Expires
2024-11-08
Drug substance claim
No
Drug product claim
No
Assignee
Guangzhou Anovent Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.